EP3880690A4 - PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES - Google Patents

PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES Download PDF

Info

Publication number
EP3880690A4
EP3880690A4 EP19883897.1A EP19883897A EP3880690A4 EP 3880690 A4 EP3880690 A4 EP 3880690A4 EP 19883897 A EP19883897 A EP 19883897A EP 3880690 A4 EP3880690 A4 EP 3880690A4
Authority
EP
European Patent Office
Prior art keywords
peptides
pharmaceutical compositions
eye diseases
treating eye
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19883897.1A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3880690A2 (en
Inventor
Taegon Baik
Jong-Yun Choi
Gyoung-Wook MIN
Chun Ho Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yuyu Pharma Inc
Original Assignee
Yuyu Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuyu Pharma Inc filed Critical Yuyu Pharma Inc
Publication of EP3880690A2 publication Critical patent/EP3880690A2/en
Publication of EP3880690A4 publication Critical patent/EP3880690A4/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP19883897.1A 2018-11-14 2019-11-14 PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES Pending EP3880690A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862767180P 2018-11-14 2018-11-14
PCT/IB2019/001220 WO2020099925A2 (en) 2018-11-14 2019-11-14 Peptides and pharmaceutical compositions for treating eye diseases

Publications (2)

Publication Number Publication Date
EP3880690A2 EP3880690A2 (en) 2021-09-22
EP3880690A4 true EP3880690A4 (en) 2023-09-13

Family

ID=70732068

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19883897.1A Pending EP3880690A4 (en) 2018-11-14 2019-11-14 PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES

Country Status (10)

Country Link
EP (1) EP3880690A4 (https=)
JP (1) JP7522732B2 (https=)
KR (1) KR20210087539A (https=)
CN (1) CN113474356B (https=)
AU (1) AU2019378162B2 (https=)
BR (1) BR112021009341A2 (https=)
MX (1) MX2021005077A (https=)
SG (1) SG11202104178TA (https=)
TW (1) TWI865470B (https=)
WO (1) WO2020099925A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2766160C2 (ru) 2017-05-17 2022-02-08 Юю Фарма, Инк. Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
BR112021023477A2 (pt) 2019-05-21 2022-02-15 Eyebio Korea Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório
CA3170606A1 (en) * 2020-03-05 2021-09-30 Wonsang YU Treatment of inflammatory diseases with peptides and pharmaceutical compositions
EP4450079A4 (en) * 2021-12-13 2025-12-10 Eyebiokorea Inc COMPOSITION FOR THE TREATMENT OF MACULAR DEGENERATION COMPRISING A NEW PEPTIDE
KR102662922B1 (ko) * 2022-05-31 2024-05-03 주식회사 세네릭스 신규의 d-아미노산 유도체 및 이를 포함하는 약학 조성물

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
WO2017175963A1 (ko) * 2016-04-08 2017-10-12 주식회사 아이바이오코리아 연골세포 세포외기질 유래 펩타이드
EP3329929A1 (en) * 2015-07-30 2018-06-06 Inje University Industry-Academic Cooperation Foundation Pharmaceutical composition for preventing or treating dry eyes
EP3643723A1 (en) * 2017-05-17 2020-04-29 Yuyu Pharma, Inc. Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101795653B1 (ko) * 2016-05-19 2017-11-09 인제대학교 산학협력단 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
KR20180074928A (ko) * 2016-12-26 2018-07-04 주식회사 아이바이오코리아 건성안 예방 또는 치료용 동물 의약품 조성물

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
EP3329929A1 (en) * 2015-07-30 2018-06-06 Inje University Industry-Academic Cooperation Foundation Pharmaceutical composition for preventing or treating dry eyes
WO2017175963A1 (ko) * 2016-04-08 2017-10-12 주식회사 아이바이오코리아 연골세포 세포외기질 유래 펩타이드
EP3441081A1 (en) * 2016-04-08 2019-02-13 Eyebio Korea Chondrocyte extracellular matrix-derived peptide
EP3643723A1 (en) * 2017-05-17 2020-04-29 Yuyu Pharma, Inc. Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient

Also Published As

Publication number Publication date
WO2020099925A3 (en) 2020-06-25
WO2020099925A2 (en) 2020-05-22
JP7522732B2 (ja) 2024-07-25
CN113474356B (zh) 2024-12-17
SG11202104178TA (en) 2021-05-28
AU2019378162B2 (en) 2025-01-30
JP2022507404A (ja) 2022-01-18
EP3880690A2 (en) 2021-09-22
CA3119921A1 (en) 2020-05-22
CN113474356A (zh) 2021-10-01
MX2021005077A (es) 2021-08-11
KR20210087539A (ko) 2021-07-12
AU2019378162A1 (en) 2021-05-20
TW202031675A (zh) 2020-09-01
TWI865470B (zh) 2024-12-11
BR112021009341A2 (pt) 2021-08-10

Similar Documents

Publication Publication Date Title
IL276464A (en) Methods and preparations for administering therapeutic protein
EP3880690A4 (en) PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES
EP3238736A4 (en) Peptide for treating ocular diseases and composition for treating ocular diseases comprising same
IL284344A (en) Pharmaceutical preparations for the eyes and methods for the treatment of diseases of the surface of the eye
IL276244A (en) A pharmaceutical preparation for the eyes, a method for its preparation and its application
EP3818081A4 (en) COMPOSITIONS AND METHODS FOR TREATING INFLAMMASOME-RELATED DISEASES OR DISORDERS
SG11201912110YA (en) Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient
EP3192875A4 (en) Sustained-release pharmaceutical composition for treating and preventing ophthalmic diseases
EP3723750A4 (en) MEDICINAL PRODUCTS AND COMPOSITIONS TO BE ADMINISTERED BY THE EYE USE
EP3691654A4 (en) OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF EYE SURFACE DISEASES
EP3634438A4 (en) COMPOSITIONS FOR THE TREATMENT OF NETWORK DISEASES AND METHOD FOR THEIR MANUFACTURE AND USE
EP3831365A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF ATOPIC DISEASES
EP3768095A4 (en) Compositions and methods for treating diarrheal diseases
IL280952A (en) Methods and drug compounds for the treatment of ophthalmic diseases
EP3265103A4 (en) Compositions and methods for treating ocular diseases
EP3993833A4 (en) Compositions and methods for treating eye diseases
EP3856210A4 (en) EXTRACELLULAR MATRIX PROTEIN COMPOSITIONS AND WOUND TREATMENT METHODS
EP3672583A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF NEURODEGENERATIVE DISEASES
EP3823635A4 (en) CORNEAL EPITHELIAL CELLS AND PRODUCTS THEREOF FOR THE TREATMENT OF CORNEAL DISEASES
HK40042312A (en) Methods and compositions for therapeutic protein delivery
HK40074800A (en) Peptides and methods for treating diseases
HK40056006A (en) Methods and compositions for drugs to treat ophthalmic diseases
HK40053279A (en) Compositions and methods for treating nrp2-associated diseases
AU2018900077A0 (en) Pharmaceutical composition for treatment of an eye disease or condition
HK40067779A (en) Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210614

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230330

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/00 20060101ALI20230510BHEP

Ipc: A61P 27/02 20060101ALI20230510BHEP

Ipc: A61K 9/00 20060101ALI20230510BHEP

Ipc: C07K 7/06 20060101AFI20230510BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20230817

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/00 20060101ALI20230810BHEP

Ipc: A61P 27/02 20060101ALI20230810BHEP

Ipc: A61K 9/00 20060101ALI20230810BHEP

Ipc: C07K 7/06 20060101AFI20230810BHEP